Advanced Cell Therapies Market, Global Outlook and Forecast 2022-2028

February 2022 | 63 pages | ID: AE6CA5E35DD8EN
Market Monitor Global

Abstracts

Advanced cell-based therapies are promising approaches for stimulating full regeneration of cartilage lesions.

This report contains market size and forecasts of Advanced Cell Therapies in Global, including the following market information:

Global Advanced Cell Therapies Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Advanced Cell Therapies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Stem Cell Transplants Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Advanced Cell Therapies include FRC Blood Service, Fujifilm, Vericel, Advanced Cell Technology, Inc, Locate Bio Limited, Kolon TissueGene, Gamida Cell, Okyanos and Rexgenero, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Advanced Cell Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Advanced Cell Therapies Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Advanced Cell Therapies Market Segment Percentages, by Type, 2021 (%)

• Stem Cell Transplants
• CAR T-cell Therapy

Global Advanced Cell Therapies Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Advanced Cell Therapies Market Segment Percentages, by Application, 2021 (%)

• Stem Cell
• Regenerative Medicine

Global Advanced Cell Therapies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Advanced Cell Therapies Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Advanced Cell Therapies revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Advanced Cell Therapies revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• FRC Blood Service
• Fujifilm
• Vericel
• Advanced Cell Technology, Inc
• Locate Bio Limited
• Kolon TissueGene
• Gamida Cell
• Okyanos
• Rexgenero
• BioXcellerator
• Takura
• Autolus

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Advanced Cell Therapies Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Advanced Cell Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ADVANCED CELL THERAPIES OVERALL MARKET SIZE

2.1 Global Advanced Cell Therapies Market Size: 2021 VS 2028
2.2 Global Advanced Cell Therapies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Advanced Cell Therapies Players in Global Market
3.2 Top Global Advanced Cell Therapies Companies Ranked by Revenue
3.3 Global Advanced Cell Therapies Revenue by Companies
3.4 Top 3 and Top 5 Advanced Cell Therapies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Advanced Cell Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Advanced Cell Therapies Players in Global Market
  3.6.1 List of Global Tier 1 Advanced Cell Therapies Companies
  3.6.2 List of Global Tier 2 and Tier 3 Advanced Cell Therapies Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Advanced Cell Therapies Market Size Markets, 2021 & 2028
  4.1.2 Stem Cell Transplants
  4.1.3 CAR T-cell Therapy
4.2 By Type - Global Advanced Cell Therapies Revenue & Forecasts
  4.2.1 By Type - Global Advanced Cell Therapies Revenue, 2017-2022
  4.2.2 By Type - Global Advanced Cell Therapies Revenue, 2023-2028
  4.2.3 By Type - Global Advanced Cell Therapies Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Advanced Cell Therapies Market Size, 2021 & 2028
  5.1.2 Stem Cell
  5.1.3 Regenerative Medicine
5.2 By Application - Global Advanced Cell Therapies Revenue & Forecasts
  5.2.1 By Application - Global Advanced Cell Therapies Revenue, 2017-2022
  5.2.2 By Application - Global Advanced Cell Therapies Revenue, 2023-2028
  5.2.3 By Application - Global Advanced Cell Therapies Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Advanced Cell Therapies Market Size, 2021 & 2028
6.2 By Region - Global Advanced Cell Therapies Revenue & Forecasts
  6.2.1 By Region - Global Advanced Cell Therapies Revenue, 2017-2022
  6.2.2 By Region - Global Advanced Cell Therapies Revenue, 2023-2028
  6.2.3 By Region - Global Advanced Cell Therapies Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Advanced Cell Therapies Revenue, 2017-2028
  6.3.2 US Advanced Cell Therapies Market Size, 2017-2028
  6.3.3 Canada Advanced Cell Therapies Market Size, 2017-2028
  6.3.4 Mexico Advanced Cell Therapies Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Advanced Cell Therapies Revenue, 2017-2028
  6.4.2 Germany Advanced Cell Therapies Market Size, 2017-2028
  6.4.3 France Advanced Cell Therapies Market Size, 2017-2028
  6.4.4 U.K. Advanced Cell Therapies Market Size, 2017-2028
  6.4.5 Italy Advanced Cell Therapies Market Size, 2017-2028
  6.4.6 Russia Advanced Cell Therapies Market Size, 2017-2028
  6.4.7 Nordic Countries Advanced Cell Therapies Market Size, 2017-2028
  6.4.8 Benelux Advanced Cell Therapies Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Advanced Cell Therapies Revenue, 2017-2028
  6.5.2 China Advanced Cell Therapies Market Size, 2017-2028
  6.5.3 Japan Advanced Cell Therapies Market Size, 2017-2028
  6.5.4 South Korea Advanced Cell Therapies Market Size, 2017-2028
  6.5.5 Southeast Asia Advanced Cell Therapies Market Size, 2017-2028
  6.5.6 India Advanced Cell Therapies Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Advanced Cell Therapies Revenue, 2017-2028
  6.6.2 Brazil Advanced Cell Therapies Market Size, 2017-2028
  6.6.3 Argentina Advanced Cell Therapies Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Advanced Cell Therapies Revenue, 2017-2028
  6.7.2 Turkey Advanced Cell Therapies Market Size, 2017-2028
  6.7.3 Israel Advanced Cell Therapies Market Size, 2017-2028
  6.7.4 Saudi Arabia Advanced Cell Therapies Market Size, 2017-2028
  6.7.5 UAE Advanced Cell Therapies Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 FRC Blood Service
  7.1.1 FRC Blood Service Corporate Summary
  7.1.2 FRC Blood Service Business Overview
  7.1.3 FRC Blood Service Advanced Cell Therapies Major Product Offerings
  7.1.4 FRC Blood Service Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.1.5 FRC Blood Service Key News
7.2 Fujifilm
  7.2.1 Fujifilm Corporate Summary
  7.2.2 Fujifilm Business Overview
  7.2.3 Fujifilm Advanced Cell Therapies Major Product Offerings
  7.2.4 Fujifilm Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.2.5 Fujifilm Key News
7.3 Vericel
  7.3.1 Vericel Corporate Summary
  7.3.2 Vericel Business Overview
  7.3.3 Vericel Advanced Cell Therapies Major Product Offerings
  7.3.4 Vericel Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.3.5 Vericel Key News
7.4 Advanced Cell Technology, Inc
  7.4.1 Advanced Cell Technology, Inc Corporate Summary
  7.4.2 Advanced Cell Technology, Inc Business Overview
  7.4.3 Advanced Cell Technology, Inc Advanced Cell Therapies Major Product Offerings
  7.4.4 Advanced Cell Technology, Inc Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.4.5 Advanced Cell Technology, Inc Key News
7.5 Locate Bio Limited
  7.5.1 Locate Bio Limited Corporate Summary
  7.5.2 Locate Bio Limited Business Overview
  7.5.3 Locate Bio Limited Advanced Cell Therapies Major Product Offerings
  7.5.4 Locate Bio Limited Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.5.5 Locate Bio Limited Key News
7.6 Kolon TissueGene
  7.6.1 Kolon TissueGene Corporate Summary
  7.6.2 Kolon TissueGene Business Overview
  7.6.3 Kolon TissueGene Advanced Cell Therapies Major Product Offerings
  7.6.4 Kolon TissueGene Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.6.5 Kolon TissueGene Key News
7.7 Gamida Cell
  7.7.1 Gamida Cell Corporate Summary
  7.7.2 Gamida Cell Business Overview
  7.7.3 Gamida Cell Advanced Cell Therapies Major Product Offerings
  7.7.4 Gamida Cell Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.7.5 Gamida Cell Key News
7.8 Okyanos
  7.8.1 Okyanos Corporate Summary
  7.8.2 Okyanos Business Overview
  7.8.3 Okyanos Advanced Cell Therapies Major Product Offerings
  7.8.4 Okyanos Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.8.5 Okyanos Key News
7.9 Rexgenero
  7.9.1 Rexgenero Corporate Summary
  7.9.2 Rexgenero Business Overview
  7.9.3 Rexgenero Advanced Cell Therapies Major Product Offerings
  7.9.4 Rexgenero Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.9.5 Rexgenero Key News
7.10 BioXcellerator
  7.10.1 BioXcellerator Corporate Summary
  7.10.2 BioXcellerator Business Overview
  7.10.3 BioXcellerator Advanced Cell Therapies Major Product Offerings
  7.10.4 BioXcellerator Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.10.5 BioXcellerator Key News
7.11 Takura
  7.11.1 Takura Corporate Summary
  7.11.2 Takura Business Overview
  7.11.3 Takura Advanced Cell Therapies Major Product Offerings
  7.11.4 Takura Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.11.5 Takura Key News
7.12 Autolus
  7.12.1 Autolus Corporate Summary
  7.12.2 Autolus Business Overview
  7.12.3 Autolus Advanced Cell Therapies Major Product Offerings
  7.12.4 Autolus Advanced Cell Therapies Revenue in Global Market (2017-2022)
  7.12.5 Autolus Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Advanced Cell Therapies Market Opportunities & Trends in Global Market
Table 2. Advanced Cell Therapies Market Drivers in Global Market
Table 3. Advanced Cell Therapies Market Restraints in Global Market
Table 4. Key Players of Advanced Cell Therapies in Global Market
Table 5. Top Advanced Cell Therapies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Advanced Cell Therapies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Advanced Cell Therapies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Advanced Cell Therapies Product Type
Table 9. List of Global Tier 1 Advanced Cell Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Advanced Cell Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Advanced Cell Therapies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Advanced Cell Therapies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Advanced Cell Therapies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Advanced Cell Therapies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Advanced Cell Therapies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Advanced Cell Therapies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Advanced Cell Therapies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Advanced Cell Therapies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Advanced Cell Therapies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Advanced Cell Therapies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Advanced Cell Therapies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Advanced Cell Therapies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Advanced Cell Therapies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Advanced Cell Therapies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Advanced Cell Therapies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Advanced Cell Therapies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Advanced Cell Therapies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Advanced Cell Therapies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Advanced Cell Therapies Revenue, (US$, Mn), 2023-2028
Table 30. FRC Blood Service Corporate Summary
Table 31. FRC Blood Service Advanced Cell Therapies Product Offerings
Table 32. FRC Blood Service Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)
Table 33. Fujifilm Corporate Summary
Table 34. Fujifilm Advanced Cell Therapies Product Offerings
Table 35. Fujifilm Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)
Table 36. Vericel Corporate Summary
Table 37. Vericel Advanced Cell Therapies Product Offerings
Table 38. Vericel Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)
Table 39. Advanced Cell Technology, Inc Corporate Summary
Table 40. Advanced Cell Technology, Inc Advanced Cell Therapies Product Offerings
Table 41. Advanced Cell Technology, Inc Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)
Table 42. Locate Bio Limited Corporate Summary
Table 43. Locate Bio Limited Advanced Cell Therapies Product Offerings
Table 44. Locate Bio Limited Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)
Table 45. Kolon TissueGene Corporate Summary
Table 46. Kolon TissueGene Advanced Cell Therapies Product Offerings
Table 47. Kolon TissueGene Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)
Table 48. Gamida Cell Corporate Summary
Table 49. Gamida Cell Advanced Cell Therapies Product Offerings
Table 50. Gamida Cell Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)
Table 51. Okyanos Corporate Summary
Table 52. Okyanos Advanced Cell Therapies Product Offerings
Table 53. Okyanos Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)
Table 54. Rexgenero Corporate Summary
Table 55. Rexgenero Advanced Cell Therapies Product Offerings
Table 56. Rexgenero Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)
Table 57. BioXcellerator Corporate Summary
Table 58. BioXcellerator Advanced Cell Therapies Product Offerings
Table 59. BioXcellerator Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)
Table 60. Takura Corporate Summary
Table 61. Takura Advanced Cell Therapies Product Offerings
Table 62. Takura Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)
Table 63. Autolus Corporate Summary
Table 64. Autolus Advanced Cell Therapies Product Offerings
Table 65. Autolus Advanced Cell Therapies Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Advanced Cell Therapies Segment by Type in 2021
Figure 2. Advanced Cell Therapies Segment by Application in 2021
Figure 3. Global Advanced Cell Therapies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Advanced Cell Therapies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Advanced Cell Therapies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Advanced Cell Therapies Revenue in 2021
Figure 8. By Type - Global Advanced Cell Therapies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Advanced Cell Therapies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Advanced Cell Therapies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Advanced Cell Therapies Revenue Market Share, 2017-2028
Figure 12. US Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Advanced Cell Therapies Revenue Market Share, 2017-2028
Figure 16. Germany Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 17. France Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Advanced Cell Therapies Revenue Market Share, 2017-2028
Figure 24. China Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 28. India Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Advanced Cell Therapies Revenue Market Share, 2017-2028
Figure 30. Brazil Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Advanced Cell Therapies Revenue Market Share, 2017-2028
Figure 33. Turkey Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Advanced Cell Therapies Revenue, (US$, Mn), 2017-2028
Figure 37. FRC Blood Service Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Fujifilm Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Vericel Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Advanced Cell Technology, Inc Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Locate Bio Limited Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Kolon TissueGene Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Gamida Cell Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Okyanos Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Rexgenero Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. BioXcellerator Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Takura Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Autolus Advanced Cell Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)